Drawing for ENGUIDE PHARMACY

USPTO serial 99057694

ENGUIDE PHARMACY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MCBRIDE, THEODORE M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with ENGUIDE PHARMACY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Troy E. Larson

Two Liberty Place1601 Chestnut Street, TL7Philadelphia, PA 19192

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer application software for providing information regarding prescription medications; Downloadable computer application software for pharmacy patients to receive information and updates regarding pharmacy orders, and renewals and alerts regarding prescription medications; Downloadable reports of the effectiveness of tailored health messaging and support at the patient levelACTIVE—
035Mail order and Pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; drug utilization review services; pharmaceutical cost management services; Strategic business analysis and business advice regarding pharmacy benefit management, pharmaceutical end-user behavior, healthcare use behavior; market study and analysis of healthcare, healthcare benefits, and pharmacy benefits effecting health behavior change and choice at the patient level; market analysis and preparation of market analysis reports of the effectiveness of tailored health messaging and support at the patient level; providing information in the field of pharmaceutical cost management as provided to pharmacy benefit management services clients, consultants and brokers; Retail pharmacy services featuring home delivery of prescription medications; Mail order pharmacy servicesACTIVE—
041Conducting and arranging business conferences in the field of pharmacy benefit managementACTIVE—
044Advisory services and consultancy regarding healthcare; Healthcare services, namely, wellness and disease management programs; Medicare prescription coverage plan services, namely, disease management programs and complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication compliance, and providing information regarding health and safety issues regarding chronic conditions; providing medical information and analysis in the fields of healthcare, pharmaceuticals; providing medical information in the field of healthcare as provided to pharmacy benefit management services clients, consultants and brokersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 10, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 10, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 7, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 7, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 7, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Oct 7, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 7, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 9, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 9, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 9, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 8, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 8, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 8, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Mar 25, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jan 8, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 17, 2025ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Nov 11, 2025PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Oct 21, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 20, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 20, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 20, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 22, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2025DOCKASSIGNED TO EXAMINER—
Jul 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 26, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 26, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance